Claritas Pharmaceuticals, Inc.
CLAZF
$0.00
$0.000.00%
OTC PK
| 09/30/2021 | 06/30/2021 | 03/31/2021 | 12/31/2020 | 09/30/2020 | |
|---|---|---|---|---|---|
| Net Income | -30.33% | -26.99% | -1,275.31% | -- | -- |
| Total Depreciation and Amortization | -- | -- | -- | -- | -- |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 7.16% | 366.90% | 4,986.17% | -- | -- |
| Change in Net Operating Assets | -50.48% | -130.61% | 71.48% | -- | -- |
| Cash from Operations | -4,865.00% | 70.22% | 89.30% | -- | -- |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 80.00% | 99.46% | 102.62% | -- | -- |
| Cash from Investing | 80.00% | 99.46% | 102.62% | -- | -- |
| Total Debt Issued | 73.53% | 73.53% | -- | -- | -- |
| Total Debt Repaid | -- | 95.00% | 95.00% | -- | -- |
| Issuance of Common Stock | -4.79% | 12.45% | -90.40% | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 4.95% | -7.77% | -89.05% | -- | -- |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -206.32% | 133.42% | 117.99% | -- | -- |